- Headquarters
- Lund
- Founded
- 2018
- Business Model
- B2B
- Website
- asgardthx.com
- Total Funding
- $39.7M
- Last Round
- $32.8M Series AMar 2024
- Rounds
- 2
About
Oncology (IO & targeted)
Summary
Asgard Therapeutics is a Biotech company based in Lund, Sweden, founded in 2018. It has raised $39.7M in total across 2 rounds, most recently a $32.8M Series A round in Mar 2024. Investors include Novo Holdings A/S, Boehringer Ingelheim Venture Fund and Industrifonden.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2024
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
China's leading blood products manufacturer

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Global contract research organization providing comprehensive drug development and laboratory ser...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/asgard-therapeutics"><img src="https://indexed.vc/api/badge/company/asgard-therapeutics" alt="Asgard Therapeutics on Indexed.vc" width="260" height="76" /></a>

